Continuous High-Dose Intravenous Vitamin C: An Early Safety Study in Patients with Advanced Cancer High-dose intravenous vitamin C (intravenous ascorbate) differs from routine oral vitamin
High-Dose Intravenous Vitamin C Combined with Chemotherapy: An Early Clinical Study in Ovarian Cancer One important direction in research on high-dose intravenous vitamin C (intravenous
Safety and Pharmacokinetics of High-Dose Intravenous Vitamin C: A Phase I Study in Advanced Cancer An important question in research on high-dose intravenous vitamin C
Pharmacological Intravenous Vitamin C with Gemcitabine: A Phase I Study in Pancreatic Cancer One important direction in research on high-dose intravenous vitamin C (intravenous ascorbate)
High-Dose Intravenous Vitamin C Combined with Standard Therapy: A Phase I Study in Metastatic Pancreatic Cancer High-dose intravenous vitamin C (intravenous ascorbic acid) was initially
Phase I Study of High-Dose Intravenous Vitamin C in Advanced Cancer: Safety and Dose Exploration One important area of research into high-dose intravenous vitamin C
Continuous High-Dose Intravenous Vitamin C: An Early Safety Study in Patients with Advanced Cancer High-dose intravenous vitamin C, or intravenous ascorbate, differs from routine oral
High-Dose Vitamin C and Survival in Advanced Cancer: Reassessing Early Clinical Observations The relationship between high-dose ascorbate and survival in patients with advanced cancer attracted
High-Dose Vitamin C and Survival in Advanced Cancer: Revisiting the 1976 Cameron and Pauling Study In 1976, Ewan Cameron and Linus Pauling published a study
High-Dose Vitamin C and Advanced Cancer: Revisiting the Early Clinical Study by Cameron and Campbell Research into high-dose vitamin C in cancer medicine is not